(DHR)

Role: Director
Signature: /s/ James F. O'Reilly, attorney-in-fact for Elias A. Zerhouni, M.D.
Issuer symbol: DHR
Transactions as of: 15 May 2022
Transactions value $: $0
Form type: 4
Filing time: 17 May 2022, 17:19:44 UTC
Previous filing: 11 May 2022
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DHR	Common Stock	Award	$0	+372	+1.46%	$0.00	25.8K	15 May 2022	Direct	F1
holding	DHR	Common Stock						7.5K	15 May 2022	By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DHR	Director stock option (right to buy)	Award	$0	+929		$0.00	929	15 May 2022	Common Stock	929	$249.19	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Content

On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.